Conference Coverage

How to prescribe effectively for opioid use disorder


 

REPORTING FROM ACP INTERNAL MEDICINE

Duration of medical therapy

Study after study demonstrates that, when treatment stops, the risk of relapse goes up.

“We as health care providers are used to the mentality of chronic diseases, like diabetes, where you’re probably on medicine for the rest of your life,” Dr. Grossman said. “OUD is another chronic disease where you might have a patient on medication for the rest of their life, although you may not want to drum that into their head right up front. It’s kind of scary. I don’t usually talk that way with my diabetic patients when I give them their diagnosis. So, I don’t push it.

“But the reality is, to give them the best chance of health, they should be on medication for a good long time,” she added. “And that’s true for all of the OUD medications.”

The role of counseling

The best evidence of the utility of adjunctive counseling in the treatment of OUD comes from the landmark Prescription Opioid Addiction Treatment Study (POATS), a 653-patient multicenter trial conducted by the National Drug Abuse Treatment Network and funded by the National Institute on Drug Abuse. Participants were randomized to standard medical management including medication and a meeting with a physician every 1-2 weeks, or to standard therapy plus individual counseling with a trained substance use counselor.

To the surprise of many, given that SAMHSA guidance strongly recommends counseling and other forms of behavioral therapy, there was no difference in outcomes between the two groups (Drug Alcohol Depend. 2015 May 1;150:112-9).

Subsequent parsing of the POATS data showed that the subgroup of people who were using heroin rather than prescription pills and who actually attended at least 60% of their counseling sessions did better than if they were randomized to no counseling.

“There’s still room for quibbling about the study, but many people would say, ‘You know, it’s not a slam dunk that everybody needs counseling,’ ” the internist commented.

“So, how do we pick the right treatment for our patients with OUD? It’s what feels right for them,” Dr. Grossman cautioned. “This gets back to what we do every day in managing chronic diseases: We nudge, we encourage, we use our motivational interviewing skills to help people figure out how they can change their lives and get healthier. There’s a long list of things going on in our patients’ lives that are going to help guide that decision.

“The message here: Medication is better than no medication, but it’s not a slam dunk which medication or how,” she concluded.

Pages

Recommended Reading

EAGLES: Smoking cessation therapy did not up cardiovascular risk
Clinician Reviews
Substance use linked to conversion to schizophrenia
Clinician Reviews
Beware nonopiate meds with high street value
Clinician Reviews
The naloxone option
Clinician Reviews
Drug-related deaths continue to rise in United States
Clinician Reviews
Private Facebook chats show promise as depression, cannabis use intervention
Clinician Reviews
Buprenorphine endangers lives and health of children
Clinician Reviews
Malpractice and pain management
Clinician Reviews
Prolonged opioid use among U.S. IBD patients doubled during 2002-2016
Clinician Reviews
Nearly one-quarter of presurgery patients already using opioids
Clinician Reviews